NDC 63323-328-41 - Nafcillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-328
- Requested NDC
- 63323-328-41
- Package NDCs from labels
- 63323-328-21, 63323-328-20, 63323-328-41, 63323-328-22
- Manufacturer
- Fresenius Kabi USA, LLC | Istituto Biochimico Italiano Giovanni Lorenzini
- Effective date
- 2026-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nafcillin for Injection, USP | Fresenius Kabi USA, LLC | Istituto Biochimico Italiano Giovanni Lorenzini | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Nafcillin for Injection, USP | Fresenius Kabi USA, LLC | Istituto Biochimico Italiano Giovanni Lorenzini | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-328-20 | Nafcillin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 | |
| 63323-328-21 | Nafcillin | 8 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 8 | 5 | |
| 63323-328-22 | Nafcillin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 4 | |
| 63323-328-22 | Nafcillin | 8 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 8 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-328 | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20190518_c39721a3-7b22-4720-9dbd-bc82f03d2af7.zip |
| 63323-328 | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20190525_3c2581a1-8051-4d7a-a1f7-521248648dc9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-328-20 | EA - Each | 63323-328 | 80c29cfa-ca39-4b40-a3ca-81b57c54283a | 1 | 2012-07-24 |
| 63323-328-21 | EA - Each | 63323-328 | ef28c6b0-e163-4fc7-85b4-1fde5e1fc9f9 | 1 | 2025-11-13 |
| 63323-328-22 | EA - Each | 63323-328 | a1e04f6d-efac-4fa8-a833-d6cdaede59a8 | 1 | 2018-08-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| NAFCILLIN | ACTIVE MOIETY | 4CNZ27M7RV | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nafcillin | NAFCILLIN | NorthStar Rx, LLC | 91ebf84a-310f-4271-8446-5a10a877883a | 2026-11-04 | Warnings, Adverse reactions | 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | NorthStar Rx, LLC | ae5fb012-4012-4063-b2e4-f1f927c6bf74 | 2026-11-04 | Warnings, Adverse reactions | ANDA090002 1721458 1721460 49G3001BCK |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2026-10-30 | Adverse reactions | 1Q73Q2JULR |
| Nafcillin | NAFCILLIN SODIUM | Fresenius Kabi USA, LLC | c39721a3-7b22-4720-9dbd-bc82f03d2af7 | 2026-10-20 | Warnings, Adverse reactions | ANDA090002 63323-327-10 63323-328-21 63323-327-21 63323-328-20 63323-327 63323-328 1721458 1721460 673c567f-9db8-4281-a929-edaf7c9f8d29 c39721a3-7b22-4720-9dbd-bc82f03d2af7 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Fresenius Kabi USA, LLC | 3c2581a1-8051-4d7a-a1f7-521248648dc9 | 2026-10-20 | Warnings, Adverse reactions | ANDA090002 63323-328-41 63323-328-22 63323-328 63323032841 1721460 9deaebde-85ad-424d-8c28-ba5db59da635 3c2581a1-8051-4d7a-a1f7-521248648dc9 49G3001BCK |
| Nafcillin | NAFCILLIN | ONESOURCE SPECIALTY PHARMA LIMITED | 5d271b9a-a667-0fd2-e063-6294a90a3b4a | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 49G3001BCK |
| Nafcillin | NAFCILLIN | WG Critical Care, LLC | 77999cd2-17b8-4df9-b687-d0f9b62096b9 | 2026-09-22 | Warnings, Adverse reactions | 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Sagent Pharmaceuticals | a6a4e122-b7f5-4eb5-8555-7aea6eda794b | 2026-09-01 | Warnings, Adverse reactions | 49G3001BCK |
| Nafcillin | NAFCILLIN | WG Critical Care, LLC | 4d3b0076-3780-413f-9052-b23be5f18f01 | 2026-08-25 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. | 8a00624c-c436-4102-a042-dab54022bcc2 | 2026-07-28 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 1Q73Q2JULR | |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 1Q73Q2JULR |
| NAFCILLIN SODIUM | NAFCILLIN SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | 4b3b8e52-df96-4886-e063-6294a90ac63f | 2026-03-09 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC128D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 251fd4cb-4aa4-4473-9f89-968da856eb77 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC127D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 75a008b2-9666-4bfa-ab18-6d09b43b2215 | 2025-12-18 | Warnings | 1Q73Q2JULR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.